New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- Clinical utility of comprehensive genomic profiling and targeted therapy in bili
- 1
- 4 years, 2 months ago
- The pattern of mucin 5AC (MUC5AC) expression using immunohistochemistry and its
- 1
- 4 years, 2 months ago
- The prevalence of targetable genomic alterations is substantially high in rare t
- 1
- 4 years, 2 months ago
- Immunohistochemistry analyses of LAG-3 expression across different tumor types a
- 1
- 4 years, 2 months ago
- A phase Ib/II study of olutasidenib in patients with relapsed/refractory IDH1 mu
- 1
- 4 years, 2 months ago
- Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in
- 1
- 4 years, 2 months ago
- The landscape of predictive biomarkers for ATR inhibition in Chinese solid-tumor
- 1
- 4 years, 2 months ago
- Pan-cancer analysis of FGFR1-3 genomic alterations to reveal a complex molecular
- 1
- 4 years, 2 months ago
- The forum ‘New Developments’ is closed to new topics and replies.